Showing results (1-10 of 176) with videos related to
Sort By:
Pageof 18
Cancer Cell|August 5, 2020
Clinical Challenges of Immune Checkpoint InhibitorsMaria de Miguel, Emiliano CalvoCancer Cell|November 9, 2021
T cell engagers in solid tumors kick the door downMaria de Miguel, Emiliano CalvoCurrent Opinion in Pharmacology|June 21, 2021
Adoptive cell therapy for solid tumors: Chimeric antigen receptor T cells and beyondVictor Moreno, Tatiana Hernandez, Maria de Miguel, et al.Cancer Treatment Reviews|November 6, 2020
Comparison of radiological criteria for hyperprogressive disease in response to immunotherapyAna Luiza Gomes da Morais, Maria de Miguel, José Miguel Cardenas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2020
T-cell-engaging Therapy for Solid TumorsMaria de Miguel, Pablo Umana, Ana Luiza Gomes de Morais, et al.Cancer|June 20, 2020
Increased vulnerability of clinical research units during the COVID-19 crisis and their protectionMaria de Miguel, Bernard Doger, Valentina Boni, et al.Oncology|March 30, 2021
A Predictive Score of Antitumour Activity of Novel Agents in Cancer Patients Treated in Early Phase StudiesRunhan Liu, Ana Gomes, Geriletu Ao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2006
Ethnic differences in response to epidermal growth factor receptor tyrosine kinase inhibitorsEmiliano Calvo, José BaselgaInvestigational New Drugs|July 21, 2021
Toxicity and antitumor activity of novel agents in elderly patients with cancer included in phase 1 studiesGeriletu Ao, Maria de Miguel, Ana Gomes, et al.Current Oncology Reports|February 19, 2005
Clinical experience with monoclonal antibodies to epidermal growth factor receptorEmiliano Calvo, Eric K RowinskyPageof 18